Allegheny Financial Group’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,000
Closed -$3.56K 250
2025
Q1
$3.56K Hold
15,000
﹤0.01% 231
2024
Q4
$3.15K Hold
15,000
﹤0.01% 230
2024
Q3
$2.85K Hold
15,000
﹤0.01% 242
2024
Q2
$3.04K Hold
15,000
﹤0.01% 221
2024
Q1
$3.75K Hold
15,000
﹤0.01% 205
2023
Q4
$2.89K Hold
15,000
﹤0.01% 209
2023
Q3
$3.79K Hold
15,000
﹤0.01% 192
2023
Q2
$5.93K Hold
15,000
﹤0.01% 149
2023
Q1
$4.2K Hold
15,000
﹤0.01% 164
2022
Q4
$3.75K Hold
15,000
﹤0.01% 169
2022
Q3
$6K Buy
+15,000
New +$8.85K ﹤0.01% 161

Other funds holding DRTSW

Allegheny Financial Group's DRTSW Position: Q2 2025 in Review

Allegheny Financial Group sold out of Alpha Tau Medical Warrant (DRTSW) in Q2 2025, closing a stake of 15,000 shares — an estimated $3.56K sold.

Allegheny Financial Group first reported a position in DRTSW in Q3 2022 and held it in 11 quarters. The position peaked at $6K in Q3 2022. 21 funds tracked by Wall St. Rank hold DRTSW as of Q2 2025.

  • Allegheny Financial Group reported no remaining Alpha Tau Medical Warrant position as of Q2 2025 after selling out during the quarter.
  • Allegheny Financial Group sold 15,000 Alpha Tau Medical Warrant shares in Q2 2025, an estimated $3.56K.
  • Allegheny Financial Group first reported a position in Alpha Tau Medical Warrant in Q3 2022 and held it in 11 quarters.
  • Allegheny Financial Group's Alpha Tau Medical Warrant position peaked at $6K in Q3 2022.
  • 21 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q2 2025.

Based on Allegheny Financial Group's 13F filing for Q2 2025, filed 13 Aug 2025.